These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 809163)

  • 21. Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma.
    Hirano T; Nishioka F; Murakami T
    Metabolism; 2004 Apr; 53(4):526-31. PubMed ID: 15045703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of postheparin lipolytic activity in uremia and its relationship to hypertriglyceridemia.
    Boyer JL; Scheig RL
    Proc Soc Exp Biol Med; 1970 Jul; 134(3):603-5. PubMed ID: 5431345
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia.
    Boberg J
    Acta Med Scand; 1972; 191(1-2):97-102. PubMed ID: 5032444
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triglyceride turnover: a comparison of simultaneous determinations using the radioglyceride and the lipolytic rate procedures.
    Steiner G; Murase T
    Fed Proc; 1975 Dec; 34(13):2258-62. PubMed ID: 172372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia].
    Kucerová L; Fabian E; Fabianová J
    Cas Lek Cesk; 1974 Apr; 113(17):519-22. PubMed ID: 4451922
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertriglyceridemia in patients with chronic renal insufficiency.
    McCosh EJ; Solangi K; Rivers JM; Goodman A
    Am J Clin Nutr; 1975 Sep; 28(9):1036-43. PubMed ID: 1163470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia in chronic nonnephrotic renal failure.
    Gutman RA; Shalhoub RJ; Wade AD; O'Connell JM; Recant L
    Am J Clin Nutr; 1973 Feb; 26(2):165-72. PubMed ID: 4574031
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary type V hyperlipoproteinemia in childhood.
    Yeshurun D; Chung H; Gotto AM; Taunton OD
    JAMA; 1977 Dec; 238(23):2518-20. PubMed ID: 578887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
    Ganesan D; Bass HB; McConathy WJ; Alaupovic P
    Metabolism; 1976 Nov; 25(11):1189-95. PubMed ID: 185483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein lipase and postheparin esterase activity in primary hyperlipoproteinaemia type IV and V.
    Kucerová L; Fabian E; Fabianová J
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):71-4. PubMed ID: 209676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post-heparin-lipolytic activity in acute ethanol-induced hyperlipoproteinemia (author's transl)].
    Schneider J; Kaffarnik H; Meyer-Bertenrath JG; Fuchs G
    Klin Wochenschr; 1976 Feb; 54(3):141-3. PubMed ID: 176504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias.
    Ganesan D; Bradford RH; Ganesan G; McConathy WJ; Alaupovic P; Bass HB
    J Appl Physiol; 1975 Dec; 39(6):1022-33. PubMed ID: 1213960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary type I hyperlipoproteinemia with normal lipoprotein lipase activity.
    Burton BK; Nadler HL
    J Pediatr; 1977 May; 90(5):777-9. PubMed ID: 853339
    [No Abstract]   [Full Text] [Related]  

  • 35. The lipoprotein lipase system: new understandings.
    Tan MH
    Can Med Assoc J; 1978 Mar; 118(6):675-80. PubMed ID: 207404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin-dependency of lipoprotein lipase in idiopathic hyperlipidemia].
    Horst A; Paluszak J; Zawilska K
    Pol Arch Med Wewn; 1971 Feb; 46(2):239-45. PubMed ID: 5549162
    [No Abstract]   [Full Text] [Related]  

  • 37. Dyslipoproteinemia and an inhibitor of lipolytic enzymes in Weber-Christian disease.
    Shirai K; Matsuoka N; Wong P; Fujioka S; Saito Y; Yoshida S
    Jpn J Med; 1989; 28(3):366-73. PubMed ID: 2739146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-prandial lipoprotein metabolism in nephrotic syndrome.
    Warwick GL; Packard CJ; Stewart JP; Watson TD; Burns L; Boulton-Jones JM; Shepherd J
    Eur J Clin Invest; 1992 Dec; 22(12):813-20. PubMed ID: 1478253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of triglyceride, monoglyceride, and phospholipid substrates for post-heparin lipolytic activities from normal and hypertriglyceridemic subjects.
    Vogel WC; Brunzell JD; Bierman EL
    Lipids; 1971 Nov; 6(11):805-14. PubMed ID: 5127476
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of lipolytic enzymes in the development of hyperlipidemia induced by administration of heterologous albumin in rabbits].
    Serrano DS; Nikul'cheva NG; Soliternova IB
    Biull Eksp Biol Med; 1984 Jan; 97(1):42-5. PubMed ID: 6692022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.